Citation 76530

MIMAKI,Y: KANMOTO,T: KURODA,M: SASHIDA,Y: NISHINO,A: SATOMI,Y: NISHINO,H:. (1995). STEROIDAL SAPONINS FROM THE UNDERGROUND PARTS OF HOSTA LONGIPES AND THEIR INHIBITORY ACTIVITY ON TUMOR PROMOTER-INDUCED PHOSPHOLIPID METABOLISM.. 43(7)

Citation Details

TitleSTEROIDAL SAPONINS FROM THE UNDERGROUND PARTS OF HOSTA LONGIPES AND THEIR INHIBITORY ACTIVITY ON TUMOR PROMOTER-INDUCED PHOSPHOLIPID METABOLISM.
AuthorsMIMAKI,Y: KANMOTO,T: KURODA,M: SASHIDA,Y: NISHINO,A: SATOMI,Y: NISHINO,H:
Year1995
Volume43
Issue7

Summary

Year: 1995

Journal: Unknown

Organisms and Their Experiments (1)

Hosta longipes (LILIACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified
ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA
GITONIN,F:
None
2
TUMOR PROMOTION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
GITONIN,F:
WEAK ACTIVITY
3Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
HECOGENIN-3-O-[O-BETA-D-GLUCOPYRANOSYL(1-2)-O-(BETA-D-XYLOPYRANOSYL(1-3))]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE
None
4
TUMOR PROMOTION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
HECOGENIN-3-O-[O-BETA-D-GLUCOPYRANOSYL(1-2)-O-(BETA-D-XYLOPYRANOSYL(1-3))]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE
WEAK ACTIVITY
5Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
GITOGENIN-3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-(BETA-D-GLUCOPYRANOSYL(1-3))]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE
None
6
TUMOR PROMOTION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
GITOGENIN-3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-(BETA-D-GLUCOPYRANOSYL(1-3))]-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE
WEAK ACTIVITY
7Not specified
UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
SPIROST-9-EN-12-ONE,5-ALPHA: 2-ALPHA-3-BETA-DIHYDROXY: 3-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-(O-ALPHA-L-RHAMNOPYRANOSYL(1-4)-BETA-D-GLUCOPYRANOSYL(1-3))-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE)
None
8
TUMOR PROMOTION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
SPIROST-9-EN-12-ONE,5-ALPHA: 2-ALPHA-3-BETA-DIHYDROXY: 3-O-BETA-D-GLUCOPYRANOSYL(1-2)-O-(O-ALPHA-L-RHAMNOPYRANOSYL(1-4)-BETA-D-GLUCOPYRANOSYL(1-3))-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE)
WEAK ACTIVITY
9Not specified
UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
SPIROST-9-EN-12-ONE,5-ALPHA: 2-ALPHA-3-BETA-DIHYDROXY: 3-O-(O-BETA-D-GLUCOPYRANOSYL(1-2)-O-(BETA-D-GLUCOPYRANOSYL(1-3))-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE) (25R)
None
10
TUMOR PROMOTION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
SPIROST-9-EN-12-ONE,5-ALPHA: 2-ALPHA-3-BETA-DIHYDROXY: 3-O-(O-BETA-D-GLUCOPYRANOSYL(1-2)-O-(BETA-D-GLUCOPYRANOSYL(1-3))-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE) (25R)
INACTIVE
11Not specified
UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
SPIROST-9-EN-12-ONE,5-ALPHA: 3-O-(O-BETA-D-GLUCOPYRANOSYL(1-2)-O-(BETA-D-XYLOPYRANOSYL(1-3))-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE) (25R)
None
12
TUMOR PROMOTION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
SPIROST-9-EN-12-ONE,5-ALPHA: 3-O-(O-BETA-D-GLUCOPYRANOSYL(1-2)-O-(BETA-D-XYLOPYRANOSYL(1-3))-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE) (25R)
WEAK ACTIVITY
13Not specified
UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
SPIROST-9-EN-12-ONE,5-ALPHA: 3-BETA-HYDROXY: 3-O-(O-BETA-D-GLUCOPYRANOSYL(1-2)-O-(BETA-D-XYLOPYRANOSYL(1-3))-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE) (25R)
None
14
TUMOR PROMOTION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
SPIROST-9-EN-12-ONE,5-ALPHA: 3-BETA-HYDROXY: 3-O-(O-BETA-D-GLUCOPYRANOSYL(1-2)-O-(BETA-D-XYLOPYRANOSYL(1-3))-O-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE) (25R)
INACTIVE
Show SPARQL Queries (1)